Oncternal Therapeutics, Inc.
ONCTDelisted Mar 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001260990
Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in Oncternal Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ONCT is no longer listed, and 13F filings after Q3 2024 list far fewer holders. See Q3 2024
- Institutional holders
- 1
- +1 vs. Q1 2025
- Shares held
- 175
- +175 vs. Q1 2025
- Total value
- $74
- +$74 vs. Q1 2025
- New holders
- 1
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75 |
| Q1 2026 | 1 | $74 |
| Q4 2025 | 2 | $169 |
| Q3 2025 | 1 | $73 |
| Q2 2025 | 1 | $74 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 4 | $10 |
| Q3 2024 | 23 | $471.0K |
| Q2 2024 | 26 | $3.67M |
| Q1 2024 | 24 | $4.05M |
| Q4 2023 | 41 | $4.53M |
| Q3 2023 | 52 | $2.81M |
| Q2 2023 | 53 | $3.26M |
| Q1 2023 | 55 | $7.86M |
| Q4 2022 | 59 | $9.31M |
| Q3 2022 | 61 | $8.79M |
| Q2 2022 | 75 | $12.6M |
| Q1 2022 | 79 | $18.6M |
| Q4 2021 | 84 | $30.5M |
| Q3 2021 | 77 | $56.8M |
| Q2 2021 | 85 | $65.2M |
| Q1 2021 | 67 | $82.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Oncternal Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Union Bancaire Privee, UBP SA | 175 | $74 | 0.00% | +175 | New |